Molecular docking, 3D QSAR and dynamics simulation studies of imidazo-pyrrolopyridines as janus kinase 1 (JAK 1) inhibitors
暂无分享,去创建一个
[1] Annick Panaye,et al. Comparative Molecular Field Analysis , 2011 .
[2] R. Shafer,et al. NMR structure refinement and dynamics of the K+-[d(G3T4G3)]2 quadruplex via particle mesh Ewald molecular dynamics simulations. , 1998, Biophysical journal.
[3] S. Sivan,et al. Molecular docking and 3D-QSAR studies on inhibitors of DNA damage signaling enzyme human PARP-1 , 2012, Journal of receptor and signal transduction research.
[4] T. Straatsma,et al. THE MISSING TERM IN EFFECTIVE PAIR POTENTIALS , 1987 .
[5] J. Gasteiger,et al. ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .
[6] J. Darnell,et al. Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.
[7] S. Bhattacharya,et al. Signaling through the JAK/STAT pathway, recent advances and future challenges. , 2002, Gene.
[8] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[9] R. Friesner,et al. Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides† , 2001 .
[10] Y. Tu,et al. Activation of JAK/STAT signal pathway predicts poor prognosis of patients with gliomas , 2011, Medical oncology.
[11] D. E. Patterson,et al. Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies , 1988 .
[12] V. Seifert,et al. Dietary Curcumin Attenuates Glioma Growth in a Syngeneic Mouse Model by Inhibition of the JAK1,2/STAT3 Signaling Pathway , 2010, Clinical Cancer Research.
[13] H. C. Andersen. Rattle: A “velocity” version of the shake algorithm for molecular dynamics calculations , 1983 .
[14] S. Wold,et al. PLS: Partial Least Squares Projections to Latent Structures , 1993 .
[15] G. Klebe,et al. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.
[16] N. K. Williams,et al. Dissecting specificity in the Janus kinases: the structures of JAK-specific inhibitors complexed to the JAK1 and JAK2 protein tyrosine kinase domains. , 2009, Journal of molecular biology.
[17] K. Shuai,et al. Regulation of JAK–STAT signalling in the immune system , 2003, Nature Reviews Immunology.
[18] Jane R Kenny,et al. Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2. , 2012, Journal of medicinal chemistry.
[19] D. Levy,et al. JAK-STAT Signaling: From Interferons to Cytokines* , 2007, Journal of Biological Chemistry.
[20] Bohdan Waszkowycz,et al. Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitors. , 2012, Journal of medicinal chemistry.
[21] J. O’Shea,et al. Janus kinases in immune cell signaling , 2009, Immunological reviews.
[22] Wolfgang Sippl,et al. Receptor-based 3D QSAR analysis of estrogen receptor ligands – merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods , 2000, J. Comput. Aided Mol. Des..
[23] Ying Zheng,et al. Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma , 2011, Molecular Cancer Therapeutics.
[24] Wolfgang Sippl,et al. Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors , 2001, J. Comput. Aided Mol. Des..
[25] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[26] A Tropsha,et al. Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors. , 1996, Journal of medicinal chemistry.